Loading insider details...
Beta
Latest Form 4 (Jun 11, 2026): Grant/Award of 6,000 TVRD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Tvardi Therapeutics, Inc. (TVRD) | Grant/Award | 6,000 | n/a |
| Apr 21, 2025 | Tvardi Therapeutics, Inc. (TVRD) | Grant/Award | 12,000 | n/a |
| Jun 6, 2024 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 150,647 | n/a |
| Jun 5, 2023 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 32,362 | n/a |
| Jun 6, 2022 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 11,876 | n/a |
| Jun 7, 2021 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 7,200 | n/a |
| Jun 30, 2020 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 38,000 | n/a |